GLOW 70 is the “finishing touch for those who are already lean” — a blend developed for the post–body transformation phase, focused on improving skin quality, firmness, and density, reducing the appearance of “loose/empty skin” and promoting a more even, rejuvenated look.
Its action is centred on remodelling the Extracellular Matrix (ECM): high-concentration GHK-Cu is associated with modulation of gene expression linked to collagen and elastin; TB-500 with cell migration and skin renewal; and BPC-157 with support for microcirculation and the reparative response.
In well-designed protocols, the result is an aesthetic finish with greater structure, elasticity, and radiance.
Key Benefits
- Firmer, more radiant skin
- Visibly more youthful appearance
- Restored elasticity (a “more filled” skin feel)
- proved dermal density and a more even texture
GLOW 70 is the “finishing touch for those who are already lean” — a blend developed for the post–body transformation phase, focused on improving skin quality, firmness, and density, reducing the appearance of “loose/empty skin” and promoting a more even, rejuvenated look.
Its action is centred on remodelling the Extracellular Matrix (ECM): high-concentration GHK-Cu is associated with modulation of gene expression linked to collagen and elastin; TB-500 with cell migration and skin renewal; and BPC-157 with support for microcirculation and the reparative response.
In well-designed protocols, the result is an aesthetic finish with greater structure, elasticity, and radiance.
Key Benefits
– Firmer, more radiant skin
– Visibly more youthful appearance
– Restored elasticity (a “more filled” skin feel)
– proved dermal density and a more even texture
Technical Details
Item Weight
Product Dimensions
Item model number
Item Package Quantity
Number of Handles
Batteries Required?
GLOW (blend)
Vial content: 70 mg total
Proposed reconstitution: 3.0 mL
Syringe: U-100 insulin syringe
Resulting concentration
Desired doses
2.0 mg dose
2.5 mg dose
Both fall between 8 and 11 IU, which is:
SS-31 50 mg (Elamipretide)
Cellular energy and mitochondrial health support.
SS-31 is a peptide developed to act on mitochondria, the structures responsible for cellular energy production. By supporting mitochondrial function, it may contribute to improved physical performance, muscle recovery, endurance, and support for healthy aging.
Who is it for?
SS-31 may be an option for individuals who seek to:
• Improve energy levels and overall vitality.
• Support recovery after intense training.
• Promote muscle and cardiovascular health.
• Encourage healthy aging with a focus on cellular function.
• Maintain high physical and cognitive performance.
What are the main benefits?
• Supports efficient cellular energy production.
• Helps reduce oxidative stress at the cellular level.
• Promotes muscle recovery and physical endurance.
• Supports mitochondrial health, essential for overall body function.
• May contribute to greater vitality and day-to-day performance.
How to use?
The usage protocol should be defined by a physician or qualified professional, according to individual goals and needs.
A synergistic combination developed to stimulate the body’s natural release of growth hormone (GH) in a physiology-aligned way. By acting through two complementary pathways, it supports more consistent GH pulses and IGF-1 support, helping to sustain performance, recovery, and body composition.
Key Benefits
Stimulates the body’s own GH: helps the body release growth hormone in a pattern closer to natural physiology (in “pulses”).
Supports recovery and repair: may aid recovery (sleep, post-training, regeneration) by reinforcing GH/IGF-1–related signalling.
Body composition support: associated with a better balance between lean mass and fat, supporting body recomposition.
More efficient metabolism: may promote energy utilisation and support fat and protein metabolism.
Vitality and performance: many people seek a greater sense of energy and a steadier performance rhythm throughout the protocol.
Less visceral fat, more definition.
Tesamorelin is a synthetic 44–amino acid peptide, an analogue of GHRH, with an N-terminal modification for improved stability. In studies, it acts on GHRH receptors in the anterior pituitary, stimulating endogenous release of growth hormone (GH) and increasing IGF-1 systemically and also locally in various tissues, with effects investigated in metabolism and body composition.
Key Benefits
MOTS-c is a peptide produced by the mitochondrion (the cell’s “energy plant”). It is being studied for helping the body use energy more efficiently, by stimulating a pathway similar to the one activated by exercise and by metformin. As a result, it may support the use of fat for energy and improve the way muscles take up sugar (glucose).
Key Benefits
Insulin sensitivity: significantly improves how the body processes sugar, helping to counter insulin resistance.
Weight management: supports fat oxidation and may help prevent weight gain caused by high-fat diets.
Physical performance: increases endurance capacity and mitochondrial biogenesis (the creation of new cellular “power plants”).
Longevity and anti-ageing: its replenishment is associated with protection against degenerative diseases.
Bone health: studies suggest it may help prevent osteoporosis by promoting osteoblast differentiation.
